3′UTR |
3′-untranslated regions |
5-HT |
serotonin |
ARRDC1 |
arrestin domain-containing protein-1 |
BBB |
blood–brain barrier |
CHOL |
cholesterol |
CNS |
Central Nervous System |
ECRG4 |
tumor suppressor esophageal cancer-related gene-4 |
EGFRvIII |
epidermal growth factor receptor |
EVs |
Extracellular vesicles |
GBM |
Glioblastoma |
grb10 |
growth factor receptor-bound protein 10 gene |
GSCs |
glioma stem cells |
ILVs |
intraluminal vesicles |
ISEV |
International Society of Extracellular Vesicles |
LAMP1–LAMP2 |
lysosomal-associated membrane proteins 1–2 |
LC3B-II |
microtubule-associated protein 1A/1B light chain 3B isoform II |
lncRNA |
long noncoding RNA |
lnc-TALC |
long noncoding RNA (lncRNA) associated with temozolomide (TMZ) |
m/lEVs |
medium/large extracellular vesicles |
miRNA |
microRNA |
MT1-MMP |
membrane type 1-matrix metalloproteinase |
MVBs |
multivesicular endosomes |
N-AEA |
N-arachidonoylethanolamine |
OPCs |
oligodendrocyte precursor cells |
PD-L1 |
binding of programmed death ligand-1 |
PS |
phosphatidylserine |
PTX |
paclitaxel |
RBM11 |
RNA-binding motif 11 |
S1P |
sphingosine-1-phosphate |
sEVs |
small extracellular vesicles |
SM |
sphingomyelin |
STAT3 |
activator of transcription 3 |
TAMCs |
tumor-associated myeloid cells |
Thbs-1 |
thrombospondin-1 |
TME |
tumor microenvironment |
TMZ |
temozolomide |
TRPVI |
vanilloid type I |
TSG101 |
protein tumor susceptibility protein 101 |
WT1 |
Wilms tumor-1 |
α -syn |
α-synuclein |